About

Science CRO translates frontier computational biochemistry and computational chemistry into confident, decision-useful strategy for pre-clinical drug discovery and development. Deliverables are designed to be re-executed, scrutinized, and extended, emphasizing written technical documentation, reproducible code, figures and visualizations, and concise method briefs.

Science CRO is spearheaded by Aron S. Workman, a computational chemist trained in chemistry and neurobiology, graduating summa cum laude from a top five U.S. public university. Workman has conducted interdisciplinary R&D for over fifteen years across drug development projects and related enabling technologies. Workman is published in Computational & Theoretical Chemistry (Elsevier). Workman is also the inventor on a granted, active United States patent. Email Aron Workman at aworkman@sciencecro.com.

Science CRO primarily serves small biotech startups and academic laboratory PIs, with engagements structured as fixed-scope pilots and optional troubleshooting support. Methodologically, work is delivered through versioned code repositories and explicit provenance logging, anchored to Linux and Python as non-negotiable foundations, while specialized frameworks and simulation packages are incorporated when they measurably improve results.

Science CRO does not provide clinical claims, regulated medical guidance, or regulated diagnostic advice, and work remains confined to pre-clinical research and technical documentation. Deliverables and submitted materials are treated as client-owned intellectual property upon completion, and an NDA can be crafted upon request.